arrow
返回
R

Rongping Guo

Sun Yat Sen University

6H指数
28论文数
108被引数
收录论文 9
发表时间
Influence of metabolic dysfunction-associated steatotic liver disease and metabolic risk factors on immunotherapy outcomes in hepatocellular carcinoma with chronic hepatitis B代谢功能障碍相关脂肪性肝病和代谢危险因素对慢性乙型肝炎相关肝细胞癌免疫治疗效果的影响
err2025-12-01
err0
PREAI
errWu, Xin-Tong; Yi, Jun-Zhe; Zhang, Yi-Min; Wang, Jiong-Liang; Li, Lei; Zeng, Jiang-Zheng; Ding, Ke; Fan, Yu-Wen; Liu, Xin; Zhu, Zhi-Jian; Yuan, Dao-Zu; Ning, Shang-Fu; Zhang, Jian-Zhong; You, Yong-Fei; Xu, Jie; Guo, Rong-Ping; Chen, Min-Shan; Zhao, Ming; Lyu, Ning
err分享
err收藏
Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma
err2025-01-10
err0
errOAAI
errZheng, Zehao; Guan, Renguo; Zhao, Rongce; Gan, Junyu; Xiong, Xinhao; Zou, Jing-wen; Li, Shaohua; Wang, Qiaoxuan; Wei, Wei; Mei, Jie; Guo, Rongping
err分享
err收藏
Oxaliplatin induces pyroptosis in hepatoma cells and enhances antitumor immunity against hepatocellular carcinoma
err2025-01-02
err0
PREAI
errDeng, Min; Zhao, Rongce; Zou, Hao; Guan, Renguo; Wang, Jiongliang; Lee, Carol; He, Benyi; Zhou, Jing; Li, Shaohua; Wei, Wei; Cai, Hao; Guo, Rongping
err分享
err收藏
Patients with hepatocellular carcinoma extrahepatic metastases can benefit from hepatic arterial infusion chemotherapy combined with lenvatinib plus programmed death-1 inhibitors
err2024-07-01
err4
errOAAI
errGuan, Renguo; Zhang, Nan; Deng, Min; Lin, Ye; Huang, Guanjie; Fu, Yizhen; Zheng, Zehao; Wei, Wei; Zhong, Chong; Zhao, Haitao; Mei, Jie; Guo, Rongping
err分享
err收藏